Diets
dietary glycemic load increases type-2 diabetes risk
In plain terms: Do blood-sugar-spiking carbs raise your diabetes risk?
Yes — strong evidence of a real causal link, though it comes from population studies, not trials.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: All trials, pooled (Meta-analysis)
How the studies fall
What the evidence shows
High dietary glycemic load independently raises T2D risk (Bradford-Hill-assessed causal), and the authors argue fiber/whole-grain cannot substitute for low GI/GL — held in deliberate tension with the fiber/whole-grain evidence. Note GI-advocacy author-panel allegiance.
The evidence (14)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Li 2015 · J Am Coll Cardiol | observational | mixed | high | High-GL carbohydrate sources relate to CHD risk; relevant carb-quality cohort evidence, T2D-adjacent but not direct null. |
| Jayedi 2022 · Crit Rev Food Sci Nutr | meta-analysis | supports | moderate | Umbrella review: higher dietary GL positively associated with T2D, CHD and stroke (low-moderate certainty) |
| Bhupathiraju 2014 · Am J Clin Nutr | observational | supports | high | Three large US cohorts + updated meta-analysis: higher GI/GL associated with elevated incident type-2 diabetes risk. |
| Salmeron J, et al. 1997 · JAMA | observational | supports | moderate | NHS: high-GL/low-cereal-fiber diet raised incident NIDDM |
| Livesey G, et al. (Brand-Miller) 2019 · Nutrients | meta-analysis | supports | moderate | Dose-response cohort MA + Bradford-Hill: GI/GL causal for T2D; fiber not a surrogate (allegiance caveat) |
| Willett 2002 · Am J Clin Nutr | observational | supports | moderate | Reviews prospective evidence that high rapidly-absorbed carbohydrate (GI/GL) raises type-2 diabetes risk. |
| Livesey 2013 · Am J Clin Nutr | meta-analysis | supports | moderate | Dose-response meta-analysis confirms positive GL-T2D relation once heterogeneity sources controlled. |
| Greenwood 2013 · Diabetes Care | meta-analysis | supports | moderate | Dose-response meta-analysis of prospective cohorts: higher GI and GL raise type-2 diabetes risk. |
| Dong 2011 · Br J Nutr | meta-analysis | supports | moderate | Meta-analysis of 13 cohorts: high GL RR 1.20 and high GI RR 1.16 for type-2 diabetes. |
| Barclay 2008 · Am J Clin Nutr | meta-analysis | supports | moderate | Meta-analysis of observational studies links high GI/GL to type-2 diabetes and other chronic disease risk. |
| Reynolds A, et al. (Mann) 2019 · Lancet | meta-analysis | mixed | high | Carbohydrate-quality MA: fiber/whole grain strongly protective; GI/GL show weaker associations ⚠️ correction-on-file (Crossref) - kept, corrigendum not retraction |
| Livesey 2019 · Nutrients | meta-analysis | supports | moderate | All nine Bradford-Hill criteria met for GI/GL as causal contributors to incident type-2 diabetes. |
| Lai 2023 · Crit Rev Food Sci Nutr | meta-analysis | supports | moderate | Dose-response cohort MA: high-GL white rice raises T2D risk 18%; +6% per 150 g/day |
| Ha AW. 2026 · study_type: observational | observational | mixed | moderate | Korean Ansan/Anseong cohort, 19-yr follow-up (73,545 person-yrs), 761 incident T2D; highest fruit-intake quartile HR 1.45 (95% CI 1.04-2.03) for T2D in females, but fruit-GL association only borderline (HR 1.36, 95% CI 0.98-1.91, p=0.058). |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.